Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review

Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review

Abstract Context Immune-checkpoint inhibitors (ICI) have shown significant benefits for overall survival across various cancer types. Patient-reported outcomes (PROs) are assessed in clinical trials as a measure of efficacy. However, it remains unclear to what extent current PRO instruments capture...

Full description

Bibliographic Details
Main Authors: Sara Colomer-Lahiguera, Denise Bryant-Lukosius, Sarah Rietkoetter, Lorraine Martelli, Karin Ribi, Donna Fitzpatrick-Lewis, Diana Sherifali, Angela Orcurto, Rosalyn Juergens, Manuela Eicher
Format: Article
Language:English
Published: SpringerOpen 2020-07-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Adverse events
Clinical trial
Immune-checkpoint inhibitors
Oncology
Patient-reported outcomes
Symptoms
Online Access:http://link.springer.com/article/10.1186/s41687-020-00210-z

Internet

http://link.springer.com/article/10.1186/s41687-020-00210-z

Similar Items